Yifeng Pharmacy Chain Co., Ltd.
603939
Classement en actions
#3633
Yifeng Pharmacy Chain Co., Ltd. serves as a key distributor of pharmaceutical... Yifeng Pharmacy Chain Co., Ltd. serves as a key distributor of pharmaceutical goods across China. As of March 31, 2021, the company oversaw an expansive network of approximately 6,279 retail pharmacies. These establishments are strategically situated throughout various significant Chinese provinces and municipalities, including Hunan, Hubei, Shanghai, Jiangsu, Zhejiang, Jiangxi, Guangdong, Hebei, and Beijing. The firm was founded in 2001 and has its primary corporate office located in Changsha, China.
Prix de l'action
$3.84
Capitalisation boursière
$4.65B
Changement (1 jour)
2.73%
Changement (1 an)
8.86%
Pays
CN
Échange Yifeng Pharmacy Chain Co., Ltd. (603939)
Catégorie
Healthcare
Bénéfices pour Yifeng Pharmacy Chain Co., Ltd. (603939)
Bénéfices en Jun 2026 TTM : $381.79M
Selon les derniers rapports financiers de Yifeng Pharmacy Chain Co., Ltd., les bénéfices actuels de l'entreprise sont de $381.79M. En 2023, l'entreprise a réalisé un bénéfice de $287.85M, une augmentation par rapport à celui de 2022 qui était de $272.18M. Les bénéfices affichés sur cette page correspondent aux bénéfices avant intérêts et impôts, appelés aussi EBIT.
Historique des bénéfices pour Yifeng Pharmacy Chain Co., Ltd. de 2011 à 2026
Bénéfices à la fin de chaque année
| Année | Bénéfices | Changez |
|---|---|---|
| 2026 (TTM) | $381.79M | 27.69% |
| 2024 | $299.00M | 3.87% |
| 2023 | $287.85M | 5.76% |
| 2022 | $272.18M | 29.30% |
| 2021 | $210.50M | 21.98% |
| 2020 | $172.57M | 47.57% |
| 2019 | $116.94M | 38.39% |
| 2018 | $84.50M | 28.43% |
| 2017 | $65.80M | 49.37% |
| 2016 | $44.05M | 19.39% |
| 2015 | $36.90M | 19.46% |
| 2014 | $30.89M | 38.66% |
| 2013 | $22.28M | 49.09% |
| 2012 | $14.94M | 21.08% |
| 2011 | $12.34M | 0.00% |
Bénéfices des entreprises similaires ou concurrentes
| Entreprise | Bénéfices | Différence de bénéfices | Pays |
|---|---|---|---|
| $1.35B | 253.57% |
US
|
|
| - | - |
SE
|
|
| - | - |
FR
|
|
| $26.37M | -93.09% |
US
|
|
| - | - |
IT
|
